Literature DB >> 1748565

Undegraded chromogranin A is present in serum and enters the endocytotic lysosomal pathway in kidney.

R Weiler1, H J Steiner, R Fischer-Colbrie, K W Schmid, H Winkler.   

Abstract

Analysis of human and bovine serum by immunoblotting revealed the presence of the proprotein chromogranin A. By the same method chromogranin A was also found in rat, bovine and human kidney. However this organ did not contain any chromogranin A mRNA arguing against a synthesis within this organ. By immune-electron microscopy chromogranin A immunoreactivity was found in proximal tubule cells of rat kidney. Positive immunostaining was present in small vesicles within and in close proximity to the brush border and closer to the nucleus in typical lysosomal structures. These results make it likely that chromogranin A from serum reaches kidney tubule cells by glomerular filtration and is taken up into the endocytotic lysosomal pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748565     DOI: 10.1007/bf00315996

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  50 in total

1.  Primary structure of rat chromogranin A and distribution of its mRNA.

Authors:  A Iacangelo; H Okayama; L E Eiden
Journal:  FEBS Lett       Date:  1988-01-25       Impact factor: 4.124

2.  An immunohistochemical study of the adrenal medulla of the ox. A comparison of antibodies against whole ox chromaffin granules and ox chromogranin A.

Authors:  D Hopwood
Journal:  Histochemie       Date:  1968

3.  Immunological characterization of secretory proteins of chromaffin granules: chromogranins A, chromogranins B, and enkephalin-containing peptides.

Authors:  R Fischer-Colbrie; I Frischenschlager
Journal:  J Neurochem       Date:  1985-06       Impact factor: 5.372

4.  Specific endocrine tissue marker defined by a monoclonal antibody.

Authors:  R V Lloyd; B S Wilson
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

5.  Immunological studies on the acidic chromogranins and on dopamine beta-hydroxylase (EC 1.14.2.1) of bovine chromaffin granules.

Authors:  H Hörtnagl; H Lochs; H Winkler
Journal:  J Neurochem       Date:  1974-01       Impact factor: 5.372

6.  Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues.

Authors:  A Iacangelo; H U Affolter; L E Eiden; E Herbert; M Grimes
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

7.  Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies.

Authors:  M A Takiyyuddin; A D Baron; J H Cervenka; J A Barbosa; H P Neumann; R J Parmer; P A Sullivan; D T O'Connor
Journal:  J Clin Endocrinol Metab       Date:  1991-03       Impact factor: 5.958

8.  Plasma pancreastatin-like immunoreactivity in various diseases.

Authors:  K Tateishi; A Funakoshi; H Wakasugi; H Iguchi; H Shinozaki; M Abe; S Funakoshi; H Tamamura; H Yajima; Y Matsuoka
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

9.  Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure.

Authors:  M G Ziegler; B Kennedy; E Morrissey; D T O'Connor
Journal:  Kidney Int       Date:  1990-05       Impact factor: 10.612

10.  Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum.

Authors:  D T O'Connor
Journal:  Regul Pept       Date:  1983-07
View more
  1 in total

Review 1.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.